Benjamin Diamond, MD¹, Dickran Kazandjian, MD², Marios Papadimitriou, MD^2*, Bachisio Ziccheddu^3*, Patrick Blaney, MS^4*, Monika Chojnacka, B.S.¹, Michael Durante, PhD^3*, Elizabeth Hill, MD^5*, Romanos Sklavenitis-Pistofidis, MD⁶, Kylee H Maclachlan, MBChB, PhD⁷, Ryan M. Young, PhD^8*, Saad Z Usmani, MD⁹, Faith E. Davies, MD¹⁰, Gad Getz, PhD^11*, Irene M. Ghobrial, MD⁶, Gareth J. Morgan, M.D., Ph.D.^12*, Francesco Maura, MD¹³ and Ola Landgren, MD³

¹Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
⁴NYU Perlmutter Cancer Center, New York, NY
⁵National Cancer Institute, National Institutes of Health, Bethesda, MD
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰NYU Langone Health, New York, NY
¹¹Broad Institute of MIT and Harvard, Cambridge, MA
¹²Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
¹³Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL

Anannya Patwari, MD^1*, Tanvi H. Patel, MD^2*, Ramya Bachu, MD^2*, Jean Esselmann, RN^3*, Lisa Rein, ScM^4*, Aniko Szabo, PhD^1*, Abhishek Janardan, MD^5*, Vineel Bhatlapenumarthi, MD^5*, Evanka Annyapu, BS^6*, Catherine E. Skoog, PA^3*, Areyl Goff, MSN, RN, NP^3*, Samer Al Hadidi, MD, MSc², Sabarinath Venniyil Radhakrishnan, MD, MBBS^6*, Sharmilan Thanendrarajan, MD^2*, Maurizio Zangari, MD², Frits van Rhee, MD, PhD², Binod Dhakal, MD, MS^7*, Anita D'Souza, MD, MS⁸, Meera Mohan, MD³ and Carolina Schinke, MD²

¹Medical College of Wisconsin, Milwaukee, WI
²Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
³BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Department of Statistics, Medical College of Wisconsin, Milwaukee, WI
⁵Department of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI
⁶Department of Medicine, Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI
⁷BMT and Cellular Therapy, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Yeasung Lee^1*, Francesca Bladt^1*, Dimitrios Leonardos^1,2*, Chira Mustafa, MBBS, BSc, MRCP^1*, Alexia Katsarou^1*, Maria Atta^1*, Marco Bua^3*, Ian Gabriel, PhD, BSc, FRCPath, MB, MRCP^3*, Jose Ros-Soto^3*, Alexandra Bazeos^3*, Jiri Pavlu, MD, FRCPath, MRCP³, Sandra Loaiza^3*, Emma Bray^3*, Farah O'Boyle^3*, Elisabet Nadal, MD, PhD^4*, Richard Szydlo, BSc, PhD^5*, Nicholas Crump, PhD^1*, Anastasios Karadimitris, MD, PhD^1* and Aristeidis Chaidos, MD, PhD^1*

¹Hugh & Josseline Langmuir Centre for Myeloma Research Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
²University of Ioannina Medical School, Ioannina, Greece
³Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁴Department of Pathology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁵Centre for Haematology, Imperial College London, London, United Kingdom

Sahar Khan, MB BCh, BAO (NUI, RCSI), FRCPath UK^1*, Salman Basrai^2*, Donna Reece, MD³, Sita D. Bhella, MD, MSc^4*, Vishal Kukreti, MD, FRCP, MSc⁵, Anca Prica, MD, MSc^5*, A. Keith Stewart, MBChB⁶, Suzanne Trudel, MD, FRCPC⁷, Harjot Vohra, MD, CCRP, MLT^3*, Chloe Yang, MD^4*, Sagi Abelson^8* and Christine Chen, MHPE, MD, FRCPC⁵

¹Princess Margaret Cancer Center, Toronto, ON, Canada
²Ontario Institute for Cancer Research, Mississauga, ON, Canada
³Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
⁵Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
⁶Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Ontario Institute for Cancer Research, Toronto, Canada

Chunrui Li¹, Lu-Gui Qiu², Di Wang^1*, Yongping Song, MD^3*, He Huang^4*, Jianyong Li, MD⁵, Bing Chen⁶, Jing Liu^7*, Yujun Dong^8*, Kai Hu^9*, Peng Liu^10*, Xi Zhang, PhD¹¹, Jianqing Mi^12*, Zhenyu Li^13*, Kaiyang Ding^14*, Shiyue Zhang^15*, Guang Hu^15* and Wen Wang^15*

¹Institute of Hematolog; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Tianjin, CHN
³Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴Bone Marrow Transplantation Center, Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China
⁵Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁶Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China
⁷Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
⁸Department of Hematology, Peking University First Hospital, Beijing, CHN
⁹Department of Adult Lymphoma, Beijing Boren Hospital, Beijing, China
¹⁰Department of Hematology, Zhongshan Hospital, Fudan University,Shanghai,China, Shanghai, CHN
¹¹Army medical University affiliated Xinqiao Hospital, Chongqing, China
¹²State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, CHN
¹³Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
¹⁴Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
¹⁵Nanjing IASO Biotherapeutics Ltd, Nanjing, China

Alireza Tafazzol^1*, Xiangnan Guan, PhD^2,3*, Giovanni Diaz, PhD^2,3*, Minfang Song, PhD^4*, Wenjin Li, PhD^4*, Cedric Dos Santos, PhD² and Habib Hamidi, MPH, PhD^2,3*

¹Translational Medicine - Oncology, Genentech, Inc., San Francisco, CA
²Translational Medicine - Oncology, Genentech, Inc., South San Francisco, CA
³Computational Sciences, Genentech, Inc., South San Francisco, CA
⁴Translational Medicine, Roche (China) Holding Ltd., Shanghai, China